Scleroderma will not take my smile
World Scleroderma Day 2017
We invite you from all over the world to post a picture/video with smiles on social medias like twitter, facebook, instagram etc with the hashtag #ScleroSmile
Scleroderma is a rare autoimmune disease that turns simple daily activities into real challenges. It is life-threatening and currently has no cure. But patient organisations are fighting back. Join us as we spread awareness and support research. We refuse to lose our smiles!
Also known as Systemic Sclerosis, scleroderma is a chronic disease of the connective tissue, immune and vascular systems, and presents a major diagnostic and management problem for patients and their physicians. Despite this, the past two years have witnessed important improvements in therapies and care. Early diagnosis is essential, and the first symptom is nearly always Raynaud’s.
Help us to keep smiling by donating to research!
The Federation of European Scleroderma Associations aisbl. (FESCA) is a focal umbrella support and advocacy organisation composed of the national scleroderma associations of 19 EU countries.
The Federation of European
Scleroderma Associations aisbl.
news & events
2022 highlights
Watch our highlights video showing some of our great achievements in 2022.
Are you living with diffuse scleroderma?
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
This is Living!
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.